首页> 外国专利> OSTEOCLAST DIFFERENTIATION INDUCTION INHIBITOR AND METHOD FOR INHIBITING OSTEOCLAST DIFFERENTIATION INDUCTION

OSTEOCLAST DIFFERENTIATION INDUCTION INHIBITOR AND METHOD FOR INHIBITING OSTEOCLAST DIFFERENTIATION INDUCTION

机译:破骨细胞分化诱导抑制剂和抑制破骨细胞分化诱导的方法

摘要

PPROBLEM TO BE SOLVED: To provide a method for treating diseases accompanying destruction of bone and to obtain a therapeutic agent. PSOLUTION: Destruction of bone is suppressed by making osteoclast differentiation inhibitory action of IL-4 directly act on monocytes being precursor cells of osteoclasts by modified adeno-associated virus incorporated with DNA of human interleukin-4. The osteoclast differentiation inhibitor is useful as a therapeutic agent for rheumatoid arthritis, periodontal disease, osteoporosis, etc. PCOPYRIGHT: (C)2007,JPO&INPIT
机译:

要解决的问题:提供一种治疗伴随骨破坏的疾病的方法并获得治疗剂。

解决方案:通过掺入人白介素4 DNA的改良腺伴随病毒,使IL-4的破骨细胞分化抑制作用直接作用于破骨细胞的前体细胞,从而抑制骨破坏。破骨细胞分化抑制剂可作为类风湿性关节炎,牙周病,骨质疏松症等的治疗剂。

COPYRIGHT:(C)2007,JPO&INPIT

著录项

  • 公开/公告号JP2007091623A

    专利类型

  • 公开/公告日2007-04-12

    原文格式PDF

  • 申请/专利权人 TOYAMA UNIV;

    申请/专利号JP20050281831

  • 申请日2005-09-28

  • 分类号A61K48;C12N5/10;A61K35/76;A61P19/02;A61P29;A61P1/02;A61P19/10;

  • 国家 JP

  • 入库时间 2022-08-21 21:14:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号